Donnez J, Taylor HS, Stewart EA, Bradley L, et al. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. Lancet 2022;400:896-907.
PMID: 36116480